New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses

BACKGROUND: PRR (Pattern Recognition Receptor) agonists have been widely tested as potent vaccine adjuvants. TLR7 (Toll-Like Receptor 7) and NOD2 (nucleotide-binding oligomerization domain 2) are key innate receptors widely expressed at mucosal levels. METHODS: Here, we evaluated the immunostimulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutjahr, Alice, Papagno, Laura, Vernejoul, Fabienne, Lioux, Thierry, Jospin, Fabienne, Chanut, Blandine, Perouzel, Eric, Rochereau, Nicolas, Appay, Victor, Verrier, Bernard, Paul, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393532/
https://www.ncbi.nlm.nih.gov/pubmed/32739871
http://dx.doi.org/10.1016/j.ebiom.2020.102922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393532/
https://www.ncbi.nlm.nih.gov/pubmed/32739871
http://dx.doi.org/10.1016/j.ebiom.2020.102922

Ejemplares similares